IBDEI2W1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48495,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,48495,1,4,0)
 ;;=4^I69.851
 ;;^UTILITY(U,$J,358.3,48495,2)
 ;;=^5007535
 ;;^UTILITY(U,$J,358.3,48496,0)
 ;;=I69.852^^216^2407^51
 ;;^UTILITY(U,$J,358.3,48496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48496,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
 ;;^UTILITY(U,$J,358.3,48496,1,4,0)
 ;;=4^I69.852
 ;;^UTILITY(U,$J,358.3,48496,2)
 ;;=^5007536
 ;;^UTILITY(U,$J,358.3,48497,0)
 ;;=I69.853^^216^2407^52
 ;;^UTILITY(U,$J,358.3,48497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48497,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,48497,1,4,0)
 ;;=4^I69.853
 ;;^UTILITY(U,$J,358.3,48497,2)
 ;;=^5007537
 ;;^UTILITY(U,$J,358.3,48498,0)
 ;;=I69.854^^216^2407^53
 ;;^UTILITY(U,$J,358.3,48498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48498,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
 ;;^UTILITY(U,$J,358.3,48498,1,4,0)
 ;;=4^I69.854
 ;;^UTILITY(U,$J,358.3,48498,2)
 ;;=^5007538
 ;;^UTILITY(U,$J,358.3,48499,0)
 ;;=I69.251^^216^2407^54
 ;;^UTILITY(U,$J,358.3,48499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48499,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,48499,1,4,0)
 ;;=4^I69.251
 ;;^UTILITY(U,$J,358.3,48499,2)
 ;;=^5007473
 ;;^UTILITY(U,$J,358.3,48500,0)
 ;;=I69.252^^216^2407^55
 ;;^UTILITY(U,$J,358.3,48500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48500,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,48500,1,4,0)
 ;;=4^I69.252
 ;;^UTILITY(U,$J,358.3,48500,2)
 ;;=^5007474
 ;;^UTILITY(U,$J,358.3,48501,0)
 ;;=I69.253^^216^2407^56
 ;;^UTILITY(U,$J,358.3,48501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48501,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,48501,1,4,0)
 ;;=4^I69.253
 ;;^UTILITY(U,$J,358.3,48501,2)
 ;;=^5007475
 ;;^UTILITY(U,$J,358.3,48502,0)
 ;;=I69.254^^216^2407^57
 ;;^UTILITY(U,$J,358.3,48502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48502,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,48502,1,4,0)
 ;;=4^I69.254
 ;;^UTILITY(U,$J,358.3,48502,2)
 ;;=^5007476
 ;;^UTILITY(U,$J,358.3,48503,0)
 ;;=I69.341^^216^2407^58
 ;;^UTILITY(U,$J,358.3,48503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48503,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff right dominant side
 ;;^UTILITY(U,$J,358.3,48503,1,4,0)
 ;;=4^I69.341
 ;;^UTILITY(U,$J,358.3,48503,2)
 ;;=^5007501
 ;;^UTILITY(U,$J,358.3,48504,0)
 ;;=I69.342^^216^2407^59
 ;;^UTILITY(U,$J,358.3,48504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48504,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff left dominant side
 ;;^UTILITY(U,$J,358.3,48504,1,4,0)
 ;;=4^I69.342
 ;;^UTILITY(U,$J,358.3,48504,2)
 ;;=^5133575
 ;;^UTILITY(U,$J,358.3,48505,0)
 ;;=I69.343^^216^2407^60
 ;;^UTILITY(U,$J,358.3,48505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48505,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff right nondom side
 ;;^UTILITY(U,$J,358.3,48505,1,4,0)
 ;;=4^I69.343
 ;;^UTILITY(U,$J,358.3,48505,2)
 ;;=^5007502
 ;;^UTILITY(U,$J,358.3,48506,0)
 ;;=I69.344^^216^2407^61
 ;;^UTILITY(U,$J,358.3,48506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48506,1,3,0)
 ;;=3^Monoplg low lmb fol cerebral infrc aff left nondom side
 ;;^UTILITY(U,$J,358.3,48506,1,4,0)
 ;;=4^I69.344
 ;;^UTILITY(U,$J,358.3,48506,2)
 ;;=^5133576
